Recce 327 - "antibacterial" (also being tested against COVID)
Recce 529 - antiviral
Recce 435 - antibacterial (H. pylori)
As James stated in his recent interview with Alan Kohler:
"The challenge in our communication is, when you say to the world, “we’re an antibiotic…” people get it. But you say to the world, “Oh, we’re some new category that you’ve never heard of and we’re going to try to make you understand it,” it’s too damn hard.So we just instead collectively call it an antibiotic, but as I say, nothing bio in our biotics and therefore, with our synthetic mechanism of action are able to overcome natural processes and have what we want, not what’s given to us from nature. We do have that capability against a broad range of infectious diseases in both bacterial and viral cells."
RCE Price at posting:
$1.28 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)